GetPortalImpactFactorByIdResp(projectId=1, id=c6c77386, cover=https://img.medsci.cn/images/journal/cover/2021/elf_202109271314517090.jpg, fullname=Diabetes Technology & Therapeutics, abbr=DIABETES TECHNOL THE, pyear=1999, frequence=Monthly, articleNumbers=1222, citedSelf2015=22.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.5月, reviewFee=null, pageFee=null, publishedRatio=2022年中国人文章占该期刊总数量300.00% (2019年为暂无数据), issn=1520-9156, greenSci=https://www.greensci.net/search?kw=1520-9156, scijournal=https://www.scijournal.org/impact-factor-of-DIABETES-TECHNOL-THE.shtml, medsciHotlightString=null, medsciHotlightRealtime=3.469, medsciHotlight=3.844, medsciHotlight5year=4.21878, citescore=0.0, hIndex=88, impactFactor=5.4, orgnization=Mary Ann Liebert Inc., orgnizationUrl=http://www.liebertpub.com, country=United States, countryCn=美国, isOa=null, isOaString=不清楚, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=医学 3区, smallclassCas=医学 2 区, website=http://www.liebertpub.com/overview/diabetes-technology-and-therapeutics/11/, websiteHits=8976, guideForAuthor=null, guideForAuthorHits=11, submitWebsite=https://www.liebertpub.com/manuscript/diabetes-technology-and-therapeutics/11/, submitWebsiteHits=1255, content=Published by Mary Ann Liebert. ISSN: 1520-9156.<br /><br />This new peer-reviewed quarterly journal covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. Technologies include noninvasive glucose monitoring, implantable continuous glucose sensors, novel routes of insulin administration, genetic engineering, the artificial pancreas, measures of longterm control, computer applications for case management, telemedicine, the internet, and new medications., totalCites=6600, brief=DIABETES TECHNOL THE杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=内分泌学与代谢" >内分泌学与代谢</a></strong>”子行业的偏低级别杂志, articleType=绝大部分收录论著，也接收少量其它类型文章, medsciHeat=黑红, medsciComment=DIABETES TECHNOL THE在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=c6c77386'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=216, tagName=糖尿病, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=1.44), GetImpactFactorCiteScoreListResponse(year=2017, citescore=1.58), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.53), GetImpactFactorCiteScoreListResponse(year=2019, citescore=8.1), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.603), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.936), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=4.61), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.729), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=3.469)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Health Professions - Medical Laboratory Technology , rank=4/27), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Endocrinology, Diabetes and Metabolism , rank=82/211), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Endocrinology , rank=52/118)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1520-9156[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=DIABETES TECHNOLOGY & THERAPEUTICS[ta], article_number=693, article_number_cn=3, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)